{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T15:25:46Z","timestamp":1779117946269,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.cancergencyto.2009.01.017","type":"journal-article","created":{"date-parts":[[2009,5,15]],"date-time":"2009-05-15T16:46:56Z","timestamp":1242406016000},"page":"73-77","source":"Crossref","is-referenced-by-count":43,"title":["A functional insertion\/deletion polymorphism in the promoter region of the NFKB1 gene increases susceptibility for prostate cancer"],"prefix":"10.1016","volume":"191","author":[{"given":"Peng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2009.01.017_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"Cancer J Clin"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib2","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/01.ju.0000142058.99614.ff","article-title":"The role of inflammation in the pathogenesis of prostate cancer","volume":"172","author":"Nelson","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJMra021562","article-title":"Prostate cancer","volume":"349","author":"Nelson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib4","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib5","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/carcin\/bgh317","article-title":"Prostate carcinogenesis and inflammation: emerging insights","volume":"26","author":"Palapattu","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jcb.10747","article-title":"Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment","volume":"91","author":"De Marzo","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib7","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1097\/01.ju.0000108142.53241.47","article-title":"Inflammation as a target for prostate cancer chemoprevention: pathological and laboratory rationale","volume":"171","author":"Lucia","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib8","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/01.ju.0000108131.43160.77","article-title":"Epidemiology of inflammation and prostate cancer","volume":"171","author":"Platz","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib9","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1073\/pnas.0437939100","article-title":"IL-1 is required for tumor invasiveness and angiogenesis","volume":"100","author":"Voronov","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/pros.10238","article-title":"Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate","volume":"56","author":"Steiner","year":"2003","journal-title":"The Prostate"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib11","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/sj.bjc.6601814","article-title":"Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer","volume":"90","author":"Michalaki","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib12","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.1073\/pnas.0402048101","article-title":"Secreted transforming growth factor beta2 activates NF-kappaB, blocks apoptosis, and is essential for the survival of some tumor cells","volume":"101","author":"Lu","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib13","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/pros.20424","article-title":"Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells","volume":"66","author":"Lu","year":"2006","journal-title":"The Prostate"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/clinchem\/45.1.7","article-title":"New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases","volume":"45","author":"Chen","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BJ20040544","article-title":"Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology","volume":"382","author":"Beinke","year":"2004","journal-title":"The Biochem J"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib16","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/154405910508401105","article-title":"NF-kappaB activation in human dental pulp stem cells by TNF and LPS","volume":"84","author":"Chang","year":"2005","journal-title":"J Dental Res"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib17","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1189\/jlb.72.5.995","article-title":"IL-12-dependent nuclear factor-kappaB activation leads to de novo synthesis and release of IL-8 and TNF-alpha in human neutrophils","volume":"72","author":"Al-Mohanna","year":"2002","journal-title":"J Leuk Biol"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri1132","article-title":"The immunological and genetic basis of inflammatory bowel disease","volume":"3","author":"Bouma","year":"2003","journal-title":"Nat Rev"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib19","first-page":"145","article-title":"Melanoma cell extravasation under flow conditions is modulated by leukocytes and endogenously produced interleukin 8","volume":"2","author":"Dong","year":"2005","journal-title":"Mol Cell Biomech"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/hmg\/ddh008","article-title":"Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis","volume":"13","author":"Karban","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.gene.6364174","article-title":"Functional variants in SUMO4, TAB2, and NFkappaB and the risk of type 1 diabetes","volume":"6","author":"Kosoy","year":"2005","journal-title":"Genes Immun"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib22","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.2741\/2375","article-title":"SNPs associated with prostate cancer risk and prognosis","volume":"12","author":"Naylor","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2005.11.019","article-title":"Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers","volume":"243","author":"Lin","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00403-008-0843-4","article-title":"Association study of NFKB1 and SUMO4 polymorphisms in Chinese patients with psoriasis vulgaris","volume":"300","author":"Li","year":"2008","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib25","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.juro.2006.04.033","article-title":"The influence of chronic inflammation in prostatic carcinogenesis: a 5-year followup study","volume":"176","author":"MacLennan","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib26","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0022-5347(05)67289-8","article-title":"Cytokine variations in patients with hormone treated prostate cancer","volume":"164","author":"Wise","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib27","first-page":"2702","article-title":"Serum interleukin 6 as a prognostic factor in patients with prostate cancer","volume":"6","author":"Nakashima","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib28","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0090-4295(01)01405-4","article-title":"Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis","volume":"58","author":"Shariat","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nature Rev"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib30","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1158\/0008-5472.CAN-06-3547","article-title":"Systemic targeting inhibitor of kappaB kinase inhibits melanoma tumor growth","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib31","doi-asserted-by":"crossref","first-page":"32491","DOI":"10.1074\/jbc.M704434200","article-title":"Modulation of NFkappaB activity and E-cadherin by the type III transforming growth factor beta receptor regulates cell growth and motility","volume":"282","author":"Criswell","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.07.013","article-title":"IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer","volume":"118","author":"Greten","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.cancergencyto.2009.01.017_bib33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature02924","article-title":"NF-kappaB functions as a tumour promoter in inflammation-associated cancer","volume":"431","author":"Pikarsky","year":"2004","journal-title":"Nature"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460809000909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460809000909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T05:03:13Z","timestamp":1684990993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460809000909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0165460809000909"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2009.01.017","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}